Early vulvar lichen sclerosus: a histopathological challenge

Vulvar lichen sclerosus (LS), a lymphocyte‐mediated chronic skin disease, begins with uncharacteristic symptoms and progresses undiagnosed to atrophy and destructive scarring. Some patients with longstanding advanced LS have an increased risk of vulvar carcinoma. Early LS is treatable, although not curable, if diagnosed early. Therefore, patients with persistent vulvar symptoms should be biopsied to establish the diagnosis. In contrast to advanced LS, the histological features in early LS are quite subtle and often more prominent in adnexal structures than in interfollicular skin. Adnexal structures show acanthosis, luminal hyperkeratosis and hypergranulosis with/without dystrophic hair and basement membrane thickening. The epidermis/mucosa shows mild irregular, occasionally psoriasiform acanthosis and focal basement membrane thickening. Early dermal changes are homogenized collagen and wide ectatic capillaries in dermal papillae immediately beneath the basement membrane. The lymphocytic infiltrate can be sparse or dense, lichenoid or interstitial with epidermal lymphocyte exocytosis and lymphocytic/lymphohistiocytic vasculitis. Dermal melanophages indicate preceding keratinocyte/melanocyte destruction. Biopsy specimens of early LS rarely display all features. Therefore, serial sections and periodic acid–Schiff reactions are necessary for their identification. Recognition and treatment of these early stages of LS may result in longstanding remission. Progression to atrophic stages with their associated morbidity and even to squamous cell carcinoma may be prevented.

[1]  C. Beham‐Schmid,et al.  Monoclonal γ-T-Cell Receptor Rearrangement in Vulvar Lichen Sclerosus and Squamous Cell Carcinomas , 2002 .

[2]  M. Klintschar,et al.  Fetal microchimerism is common in normal and diseased vulvar skin. , 2004, The Journal of investigative dermatology.

[3]  F. Wojnarowska,et al.  Does treatment of vulvar lichen sclerosus influence its prognosis? , 2004, Archives of dermatology.

[4]  V. Bonney,et al.  LEUCOPLAKIC VULVITIS AND ITS RELATION TO KRAUROSIS VULVAE AND CARCINOMA VULVAE , 1909, British medical journal.

[5]  M. Mihm,et al.  Non-neoplastic epithelial alterations of the vulva: recognition assessment and comparisons of terminologies used among the various specialties. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[6]  R. Thomas,et al.  Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women , 1988, The British journal of dermatology.

[7]  S. Regauer Immune dysregulation in lichen sclerosus. , 2005, European journal of cell biology.

[8]  J. Scurry,et al.  Vulvar squamous cell carcinoma and lichen sclerosus , 1997, The Australasian journal of dermatology.

[9]  J. Muche,et al.  Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. , 2000, The Journal of investigative dermatology.

[10]  C. Beham‐Schmid,et al.  Monoclonally rearranged gamma T-cell receptor in lichen sclerosus--a finding of clinical significance? , 2004, American journal of dermatopathology.

[11]  J. McGrath,et al.  Autoantibodies to extracellular matrix protein 1 in lichen sclerosus , 2003, The Lancet.

[12]  N. Maclaren,et al.  Genetic aspects of vulvar lichen sclerosus. , 1984, American journal of obstetrics and gynecology.

[13]  I. Wistuba,et al.  Human papillomavirus, lichen sclerosis and vulvar squamous cell carcinoma , 1998 .

[14]  C. Beham‐Schmid,et al.  Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. , 2002, The American journal of pathology.

[15]  Byrén,et al.  Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease , 1999, The British journal of dermatology.

[16]  Gabriel White spot disease. , 1946, Wiener klinische Wochenschrift.

[17]  P. Leboit,et al.  Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus. , 1998, The American journal of surgical pathology.

[18]  I. Dunsmore,et al.  An investigation into the incidence of auto‐immune disorders in patients with lichen sclerosus and atrophicus , 1981, The British journal of dermatology.

[19]  C. Kreibich,et al.  Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.

[20]  S. Goolamali,et al.  Organ-specific Antibodies in Patients with Lichen Sclerosus , 1974, British medical journal.

[21]  R. Thomas,et al.  The association of lichen sclerosus et atrophicus and autoimmune‐related disease in males , 1983, The British journal of dermatology.

[22]  T. Jeffcoate Chronic vulval dystrophies. , 1966, American journal of obstetrics and gynecology.

[23]  R. Porcher,et al.  Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. , 2004, Archives of dermatology.

[24]  M. Mihm,et al.  Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[25]  S. Neill,et al.  Guidelines for the management of lichen sclerosus , 2002, The British journal of dermatology.

[26]  C. Ridley,et al.  Lichen sclerosus et atrophicus associated with systemic lupus erythematosus. , 1985, Journal of the American Academy of Dermatology.

[27]  A. Biggeri,et al.  Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.